The global Cell-based Assay Market Growth Accelerated by Rise in Healthcare Awareness
Cell-based assays allow for characterization of protein
expression, cell signaling pathway activity, and drug effectiveness. They
provide a more biologically relevant environment than alternatives like ELISA.
With the growing healthcare awareness and expenditure, demand for improved
diagnostics and personalized medicine is increasing. This is driving the
adoption of cell-based assays in drug discovery and development.
Market key trends:
The rise in healthcare awareness has been a key factor fuelling the growth of cell-based assays. As people are becoming more conscious about their health and willing to spend more on quality healthcare services, the demand for cell-based assay is increasing. Cell-based assays help in developing new treatments at a faster pace by offering more insights into complex disease mechanisms. They allow screening of potential drug candidates at an early stage, reducing failure rates later. This is saving significant costs and time for pharmaceutical companies. Growing funding for cell-based research from public and private sources is also supporting the adoption of advanced cell-based technologies. As cell-based assays gain more prominence in life science research and drug development, their market is expected to grow at a steady rate over the coming years.
Segment Analysis
The global cell-based assay market is segmented on the basis of technology, application, end-use, and geography. Based on technology, the consumables segment dominates the market and is expected to witness the highest growth during the forecast period. The increasing demand for consumables from biotechnology and pharmaceutical companies for screening, identification, and validation of drug candidates is a key factor driving the segment's growth. Within consumables, reagents and assay kits account for the largest share as they are widely used in cell-based assays for numerous applications.
Key Takeaways
The global cell-based assay market is expected to witness high growth. The North America region currently dominates the market due to presence of key market players and availability of advanced healthcare infrastructure to adopt new technologies. Growth in the region is expected to be driven by rising adoption of cell-based assays in drug discovery, availability of funding for cell-based research, and presence of major market players.
Key players operating in the cell-based assay market are DiscoverX Corporation, Becton, Dickinson and Company, cell Signaling Technology, Inc., Becton, Danaher Corporation, Thermo Fisher Scientific, Inc., Cisbio Bioassays, Merck & Co., and PerkinElmer, Inc. and others. Thermo Fisher Scientific and Danaher Corporation are two of the leading players in the market. Thermo Fisher Scientific offers comprehensive cell-based assay kits and instruments for detection and validation of cancer biomarkers, antibiotic resistance, and protein interaction studies. Danaher Corporation provides consumables, instruments, software and services for cell-based assays through its subsidiaries such as Beckman Coulter Life Sciences and Molecular Devices.
The global cell-based assay market is expected to witness high growth. Regional analysis related content comprises the North America region holds the largest share in the global cell-based assay market. The dominance of this region is attributed to presence of key market players, availability of funding for development of new drug discovery technologies, and growing R&D expenditure by biotechnology and pharmaceutical companies. Europe is the second largest market for cell-based assays driven by presence of major pharmaceutical companies in countries such as Germany and U.K. Asia Pacific region is expected to grow at the highest CAGR during the forecast period due large patient pool, partnerships between regional and global market players, and increasing focus of contract research organizations on cell-based assays.
Comments
Post a Comment